AptarGroup, Inc. - ATR

ATR Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ATR	-0.2	2.2	-4.3	-7.0	7.8	23.2	29.7	33.0	143.1	3098.6
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare ATR with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ATR
name	AptarGroup, Inc.
price	156.09
changes percentage	-0.20
change	-0.32
day low	155.68
day high	157.95
year high	178.03
year low	128.05
market cap	10386728088
price avg 50	165.55
price avg 200	153.42
exchange	NYSE
volume	187574
avg volume	280208
open	156.97
previous close	156.41
eps	5.01
pe	31.16
earnings announcement	2025-02-06T21:00:00.000+0000
shares outstanding	66543200
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 73.3%

Overall Quarterly Financial Health: 56.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000896622
revenue	3487450000	3322249000	4.97
gross profit	1263399000	1163838000	8.55
gross profit ratio	0.36	0.35	3.41
research and development expenses	92800000	544262000	-82.95
operating expenses	852528999	777968000	9.58
interest income	4373000	2700000	61.96
interest expense	40418000	40827000	-1.00
ebitda	663836000	609408000	8.93
ebitdaratio	0.19	0.19	2.34
operating income	404019000	379273000	6.52
operating income ratio	0.12	0.11	1.48
net income	284487000	239288000	18.89
net income ratio	0.08	0.07	13.26
eps	4.34	3.66	18.58

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3,487 million in 2023 from 3,322 million in 2022 representing a change of 4.97%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,263 million in 2023 from 1,164 million in 2022 representing a change of 8.55%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 93 million in 2023 from 544 million in 2022 representing a change of -82.95%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 664 million in 2023 from 609 million in 2022 representing a change of 8.93%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 404 million in 2023 from 379 million in 2022 representing a change of 6.52%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 284 million in 2023 from 239 million in 2022 representing a change of 18.89%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 4.34 in 2023 from 4.34 in 2022 representing a change of 18.58%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 853 million in 2023 from 778 million in 2022 representing a change of 9.58%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000896622
revenue	909291000	910063000	-0.08
gross profit	350780000	277655000	26.34
gross profit ratio	0.39	0.31	26.44
research and development expenses	0	149330000	-100.00
operating expenses	212483000	145930000	45.61
interest income	3022000	3102000	-2.58
interest expense	12290000	10061000	22.15
ebitda	210436000	193275000	8.88
ebitdaratio	0.23	0.22	7.08
operating income	138297000	131725000	4.99
operating income ratio	0.15	0.14	5.08
net income	100039000	90454000	10.60
net income ratio	0.11	0.1	10.69
eps	1.51	1.36	11.03

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 909 million in 2024Q3 from 910 million in 2024Q2 representing a change of -0.08%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q3 from 149 million in 2024Q2 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 212 million in 2024Q3 from 146 million in 2024Q2 representing a change of 45.61%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 100 million in 2024Q3 from 90 million in 2024Q2 representing a change of 10.6%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 351 million in 2024Q3 from 278 million in 2024Q2 representing a change of 26.34%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 210 million in 2024Q3 from 193 million in 2024Q2 representing a change of 8.88%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 138 million in 2024Q3 from 132 million in 2024Q2 representing a change of 4.99%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 1.51 in 2024Q3 from 1.51 in 2024Q2 representing a change of 11.03%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000896622
total assets	4451890000	4203458000	5.91
total liabilities	2130592000	2135254000	-0.22
total equity	2321298000	2068204000	12.24
cash and cash equivalents	223643000	141732000	57.79
short term investments	0	89424000	-100.00
long term investments	49203000	52308000	-5.94
total current assets	1549279000	1430291000	8.32
total non current assets	2902611000	2773167000	4.67
total current liabilities	1251309000	917176000	36.43
total non current liabilities	879283000	1218078000	-27.81
common stock	717000	709000	1.13
retained earnings	2109816000	1929240000	9.36
total debt	1184675000	1175388000	0.79

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 4,452 million in 2023 from 4,203 million in 2022 representing a change of 5.91%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 2,131 million in 2023 from 2,135 million in 2022 representing a change of -0.22%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 2,321 million in 2023 from 2,068 million in 2022 representing a change of 12.24%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 224 million in 2023 from 142 million in 2022 representing a change of 57.79%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,549 million in 2023 from 1,430 million in 2022 representing a change of 8.32%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2023 from 1 in 2022 representing a change of 1.13%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 2,110 million in 2023 from 1,929 million in 2022 representing a change of 9.36%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 89 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 1,251 million in 2023 from 917 million in 2022 representing a change of 36.43%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 1,185 million in 2023 from 1,175 million in 2022 representing a change of 0.79%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000896622
total assets	4625215000	4453257000	3.86
total liabilities	2071574000	2043042000	1.40
total equity	2553641000	2410215000	5.95
cash and cash equivalents	325524000	221492000	46.97
short term investments	2387000	2399000	-0.50
long term investments	51052000	48527000	5.20
total current assets	1665604000	1593650000	4.52
total non current assets	2959611000	2859606999	3.50
total current liabilities	1026652000	1168109000	-12.11
total non current liabilities	1044922000	874933000	19.43
common stock	723000	721000	0.28
retained earnings	2299540000	2229377000	3.15
total debt	1134707000	1130587000	0.36

Overall Score of Quarterly Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 4,625 million in 2024Q3 from 4,453 million in 2024Q2 representing a change of 3.86%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 2,554 million in 2024Q3 from 2,410 million in 2024Q2 representing a change of 5.95%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 326 million in 2024Q3 from 221 million in 2024Q2 representing a change of 46.97%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 1,666 million in 2024Q3 from 1,594 million in 2024Q2 representing a change of 4.52%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 1,027 million in 2024Q3 from 1,168 million in 2024Q2 representing a change of -12.11%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 1 in 2024Q3 from 1 in 2024Q2 representing a change of 0.28%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 2,300 million in 2024Q3 from 2,229 million in 2024Q2 representing a change of 3.15%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 2,072 million in 2024Q3 from 2,043 million in 2024Q2 representing a change of 1.4%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 2 million in 2024Q3 from 2 million in 2024Q2 representing a change of -0.5%. This indicates a decrease in short-term investment holdings.

  Total Debt: Total Debt increased to 1,135 million in 2024Q3 from 1,131 million in 2024Q2 representing a change of 0.36%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000896622
net change in cash	81411000	19807000	311.02
operating cash flow	575239000	478617000	20.19
free cash flow	256836000	163001000	57.57
capital expenditure	-318403000	-315616000	-0.88
depreciation and amortization	248593000	233706000	6.37
deferred income tax	-19883000	-12106000	-64.24
stock based compensation	41293000	40937000	0.87
accounts payables	14596000	55098000	-73.51
inventory	0	-60354000	100.00
acquisitions net	-16570000	-4100000	-304.15
investments in property plant and equipment	-318403000	-315616000	-0.88
net cash used for investing activites	-324463000	-295642000	-9.75
debt repayment	-51552000	4988000	-1,133.52
common stock issued	0	0	NaN
common stock repurchased	-47552000	-92126000	48.38
dividends paid	-103683000	-99461000	-4.24
net cash used provided by financing activities	-171554000	-162096000	-5.83
cash at end of period	224143000	142732000	57.04
accounts receivables	15431000	-27937000	155.23
cash at beginning of period	142732000	122925000	16.11

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 81 million in 2023 from 20 million in 2022 representing a change of 311.02%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 575 million in 2023 from 479 million in 2022 representing a change of 20.19%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 257 million in 2023 from 163 million in 2022 representing a change of 57.57%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -318 million in 2023 from -316 million in 2022 representing a change of -0.88%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 15 million in 2023 from 55 million in 2022 representing a change of -73.51%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 41 million in 2023 from 41 million in 2022 representing a change of 0.87%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 15 in 2023 from -28 million in 2022 representing a change of 155.23%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -104 million in 2023 from -99 million in 2022 representing a change of -4.24%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000896622
operating cash flow	229262000	143579000	59.68
free cash flow	149470000	75374000	98.30
capital expenditure	-79792000	-68205000	-16.99
depreciation and amortization	67015000	64968000	3.15
deferred income tax	-3514000	-181000	-1,841.44
stock based compensation	10409000	9277000	12.20
accounts receivables	54306000	-21833000	348.73
accounts payables	-17280000	-1803000	-858.40
inventory	8940000	6447000	38.67
acquisitions net	5361000	845000	534.44
investments in property plant and equipment	-79792000	-68205000	-16.99
net cash used for investing activites	-80670000	-68414000	-17.91
debt repayment	-21163000	-26488000	20.10
common stock issued	0	0	NaN
common stock repurchased	-14169000	-5058000	-180.13
dividends paid	-29876000	-27168000	-9.97
net cash used provided by financing activities	-48641000	-53257000	8.67
net change in cash	104032000	21658000	380.34
cash at end of period	325524000	221492000	46.97
cash at beginning of period	221492000	199834000	10.84

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 104 million in 2024Q3 from 22 million in 2024Q2 representing a change of 380.34%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 229 million in 2024Q3 from 144 million in 2024Q2 representing a change of 59.68%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 149 million in 2024Q3 from 75 million in 2024Q2 representing a change of 98.3%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -80 million in 2024Q3 from -68 million in 2024Q2 representing a change of -16.99%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 10 million in 2024Q3 from 9 million in 2024Q2 representing a change of 12.2%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 17 million in 2024Q3 from 2 million in 2024Q2 representing a change of -858.4%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 54 in 2024Q3 from -22 million in 2024Q2 representing a change of 348.73%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -30 million in 2024Q3 from -27 million in 2024Q2 representing a change of -9.97%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	53.15	50.8	4.63
net income per share	4.34	3.66	18.50
operating cash flow per share	8.77	7.32	19.80
free cash flow per share	3.91	2.49	57.05
cash per share	3.41	3.53	-3.57
book value per share	35.38	31.62	11.87
tangible book value per share	16.38	17.16	-4.58
shareholders equity per share	35.16	31.4	11.95
interest debt per share	18.67	18.6	0.40
market cap	8111449920	7192911960	12.77
enterprise value	9072481920	8226567960	10.28
pe ratio	28.51	30.06	-5.15
price to sales ratio	2.33	2.17	7.43
pocfratio	14.1	15.03	-6.17
pfcf ratio	31.58	44.13	-28.43
pb ratio	3.52	3.5	0.41
ptb ratio	3.52	3.5	0.41
ev to sales	2.6	2.48	5.06
enterprise value over ebitda	13.67	13.5	1.24
ev to operating cash flow	15.77	17.19	-8.24
ev to free cash flow	35.32	50.47	-30.01
earnings yield	0.04	0.03	5.43
free cash flow yield	0.03	0.02	39.72
debt to equity	0.51	0.57	-10.26
debt to assets	0.27	0.28	-4.83
net debt to ebitda	1.45	1.7	-14.65
current ratio	1.24	1.56	-20.60
interest coverage	10.0	9.29	7.60
income quality	2.02	2.0	1.32
dividend yield	0.01	0.01	-7.56
payout ratio	0.36	0.42	-12.32
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.03	0.16	-83.76
intangibles to total assets	0.28	0.22	24.47
capex to operating cash flow	0.55	0.66	-16.06
capex to revenue	0.09	0.1	-3.90
capex to depreciation	1.28	1.35	-5.16
stock based compensation to revenue	0.01	0.01	-3.91
graham number	58.56	50.85	15.18
roic	0.08	0.08	3.71
return on tangible assets	0.09	0.07	20.84
graham net net	-17.2	-17.44	1.36
working capital	297970000	513115000	-41.93
tangible asset value	1074669000	1122572000	-4.27
net current asset value	-581313000	-704963000	17.54
invested capital	3081736000	2802411000	9.97
average receivables	694789000	682536500	1.80
average payables	324426000	302771500	7.15
average inventory	499929500	464135000	7.71
days sales outstanding	72.83	76.22	-4.44
days payables outstanding	53.92	54.16	-0.44
days of inventory on hand	84.2	82.32	2.28
receivables turnover	5.01	4.79	4.65
payables turnover	6.77	6.74	0.44
inventory turnover	4.33	4.43	-2.23
roe	0.12	0.12	5.86
capex per share	4.85	4.83	0.55

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 28.51 on 2023-12-31 from 30.06 on 2022-12-31, representing a change of -5.15%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.24 on 2023-12-31 from 1.56 on 2022-12-31, representing a change of -20.60%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.51 on 2023-12-31 from 0.57 on 2022-12-31, representing a change of -10.26%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
ATR
calendar year	2024	2024	NaN
revenue per share	13.68	13.72	-0.28
net income per share	1.51	1.36	10.38
operating cash flow per share	3.45	2.17	59.36
free cash flow per share	2.25	1.14	97.91
cash per share	4.94	3.38	46.17
book value per share	38.43	36.35	5.74
tangible book value per share	19.78	18.12	9.13
shareholders equity per share	38.21	36.14	5.74
interest debt per share	17.26	17.2	0.36
market cap	10643824550	9186864480	15.86
enterprise value	11453007550	10095959480	13.44
pe ratio	26.6	25.39	4.76
price to sales ratio	11.71	10.09	15.96
pocfratio	46.43	63.98	-27.44
pfcf ratio	71.21	121.88	-41.58
pb ratio	4.19	3.83	9.35
ptb ratio	4.19	3.83	9.35
ev to sales	12.6	11.09	13.54
enterprise value over ebitda	54.43	52.24	4.19
ev to operating cash flow	49.96	70.32	-28.96
ev to free cash flow	76.62	133.94	-42.79
earnings yield	0.01	0.01	-4.54
free cash flow yield	0.01	0.01	71.16
debt to equity	0.45	0.47	-5.27
debt to assets	0.25	0.25	-3.37
net debt to ebitda	3.85	4.7	-18.25
current ratio	1.62	1.36	18.92
interest coverage	11.25	13.09	-14.05
income quality	2.29	1.59	44.55
dividend yield	0.0	0.0	-5.09
payout ratio	0.3	0.3	-0.57
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.16	-100.00
intangibles to total assets	0.27	0.27	-1.24
capex to operating cash flow	0.35	0.48	-26.73
capex to revenue	0.09	0.07	17.09
capex to depreciation	1.19	1.05	13.42
stock based compensation to revenue	0.01	0.01	12.30
graham number	35.98	33.3	8.03
roic	0.03	0.03	0.21
return on tangible assets	0.03	0.03	6.00
graham net net	-14.51	-15.28	5.05
working capital	638952000	425541000	50.15
tangible asset value	1314133000	1201810000	9.35
net current asset value	-405970000	-449392000	9.66
invested capital	3459085000	3159051000	9.50
average receivables	732768000	746062000	-1.78
average payables	683440000	680438000	0.44
average inventory	486574000	490724000	-0.85
days sales outstanding	70.67	74.32	-4.92
days payables outstanding	110.4	97.02	13.79
days of inventory on hand	78.72	68.97	14.15
receivables turnover	1.27	1.21	5.17
payables turnover	0.82	0.93	-12.12
inventory turnover	1.14	1.3	-12.40
roe	0.04	0.04	4.39
capex per share	1.2	1.03	16.75

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of 4.39%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 26.60 on 2024-09-30 Q3 from 25.39 on 2024-06-30 Q2, representing a change of 4.76%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.62 on 2024-09-30 Q3 from 1.36 on 2024-06-30 Q2, representing a change of 18.92%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.45 on 2024-09-30 Q3 from 0.47 on 2024-06-30 Q2, representing a change of -5.27%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 110.73 which is lower than current price 156.09, indicates the company may be overvalued.